A detailed history of Empirical Finance, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Empirical Finance, LLC holds 27,540 shares of LLY stock, worth $21.6 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
27,540
Previous 26,896 2.39%
Holding current value
$21.6 Million
Previous $24.4 Million 0.19%
% of portfolio
1.44%
Previous 1.54%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $497,258 - $618,252
644 Added 2.39%
27,540 $24.4 Million
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $1.29 Million - $1.62 Million
-1,780 Reduced 6.21%
26,896 $24.4 Million
Q1 2024

May 06, 2024

BUY
$592.2 - $792.28 $673,923 - $901,614
1,138 Added 4.13%
28,676 $22.3 Million
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $1.15 Million - $1.59 Million
2,654 Added 10.67%
27,538 $14.8 Million
Q2 2023

Jul 27, 2023

BUY
$350.74 - $468.98 $959,273 - $1.28 Million
2,735 Added 12.35%
24,884 $11.7 Million
Q1 2023

Apr 05, 2023

BUY
$310.63 - $364.82 $346,041 - $406,409
1,114 Added 5.3%
22,149 $7.61 Million
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $496,473 - $578,490
1,544 Added 7.92%
21,035 $7.7 Million
Q3 2022

Nov 04, 2022

BUY
$296.48 - $337.87 $915,233 - $1.04 Million
3,087 Added 18.82%
19,491 $6.3 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $240,822 - $282,761
864 Added 5.56%
16,404 $5.32 Million
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $371,279 - $461,406
1,582 Added 11.33%
15,540 $4.45 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $814,856 - $1.01 Million
3,624 Added 35.07%
13,958 $3.86 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $120,993 - $148,899
546 Added 5.58%
10,334 $2.39 Million
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $212,146 - $274,409
1,175 Added 13.64%
9,788 $2.25 Million
Q4 2020

Feb 02, 2021

BUY
$130.46 - $172.63 $175,599 - $232,359
1,346 Added 18.52%
8,613 $1.45 Million
Q3 2020

Oct 28, 2020

BUY
$146.22 - $169.13 $734,755 - $849,878
5,025 Added 224.13%
7,267 $1.08 Million
Q3 2020

Oct 26, 2020

SELL
$146.22 - $169.13 $527,707 - $610,390
-3,609 Reduced 61.68%
2,242 $251,000
Q2 2020

Jul 20, 2020

BUY
$136.42 - $164.18 $675,142 - $812,526
4,949 Added 548.67%
5,851 $961,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $578,284 - $695,959
-4,239 Reduced 82.45%
902 $961,000
Q1 2020

Apr 16, 2020

BUY
$119.05 - $147.35 $206,313 - $255,357
1,733 Added 50.85%
5,141 $713,000
Q4 2019

Jan 27, 2020

BUY
$106.92 - $132.43 $124,668 - $154,413
1,166 Added 52.01%
3,408 $448,000
Q3 2019

Oct 30, 2019

BUY
$106.79 - $116.16 $3,951 - $4,297
37 Added 1.68%
2,242 $251,000
Q2 2019

Jul 09, 2019

SELL
$110.79 - $129.32 $4,763 - $5,560
-43 Reduced 1.91%
2,205 $244,000
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $250,224 - $294,532
2,248 New
2,248 $292,000
Q4 2018

Jan 22, 2019

SELL
$105.9 - $118.64 $203,433 - $227,907
-1,921 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$85.86 - $107.31 $164,937 - $206,142
1,921 New
1,921 $206,000
Q2 2018

Jul 09, 2018

SELL
$75.7 - $86.88 $170,173 - $195,306
-2,248 Closed
0 $0
Q1 2018

May 10, 2019

BUY
$74.21 - $87.6 $166,824 - $196,924
2,248 New
2,248 $292,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.